The Impact of the American Academy of Pediatrics Brief Resolved Unexplained Event Guidelines on Gastrointestinal Testing and Prescribing Practices.
Daniel R Duncan, Amanda S Growdon, Enju Liu...
https://pubmed.ncbi.nlm.nih.gov/31103259/Actively Recruiting
Led by Boston Children's Hospital · Updated on 2026-10-22
250
Participants Needed
1
Research Sites
N/A
Total Duration
This research aims to understand how thickened feeds affect infants who have experienced a brief resolved unexplained event BRUE, which are sudden and frightening episodes involving choking, color changes, and limpness. These events are common and require significant medical attention, but current treatments do not fully address ongoing symptoms. The study compares infants with BRUE who receive thickened feeds to those who do not over the course of one year to explore swallowing issues and their impact on health. Participants in this observational study include infants under one year old admitted after their first BRUE. Some infants receive thickened feeds as directed by their medical team, while others receive non-thickened feeds. Researchers observe these groups without changing their prescribed care to evaluate differences related to feeding types over 12 months. During the study, families provide information about their infants symptoms and hospital visits. The main focus is on how often persistent symptoms and repeat hospitalizations occur within six months, with additional monitoring extending to a full year. This helps researchers assess the longer-term effects of feeding types on infant health and healthcare use.
CONDITIONS
Effect of Thickened Feeds on Clinical Outcomes in Children With Brief Resolved Unexplained Event
D
Daniel R Duncan, MD, MPH
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Boston Children's Hospital
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - 12 months
Participants are observed over one year to track symptoms and hospital visits while receiving either thickened or non-thickened feeds as directed by their medical team.
Regular check-ins throughout the year
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Daniel R Duncan, Amanda S Growdon, Enju Liu...
https://pubmed.ncbi.nlm.nih.gov/31103259/Daniel R Duncan, Clare Golden, Amanda S Growdon...
https://pubmed.ncbi.nlm.nih.gov/38815745/Daniel R Duncan, Janine Amirault, Paul D Mitchell...
https://pubmed.ncbi.nlm.nih.gov/27741062/Daniel R Duncan, Clare Golden, Kara Larson...
https://pubmed.ncbi.nlm.nih.gov/39871744/Daniel R Duncan, Enju Liu, Amanda S Growdon...
https://pubmed.ncbi.nlm.nih.gov/36336644/Boston Children's Hospital
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsor